Bio-Techne Corporation TECH
Set alert
72.66 USD -0.05 -0.07%
At close · Oct 30
72.66 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
72.66 Day range 72.73
43.30 52-week range 72.71
- YTD
- +23.55%
- 1 year
- +19.19%
- Open
- 72.72
- Prev close
- 72.71
- Mkt cap
- 11.41B
- Vol
- 2.57M
- Avg vol
- 2.84M
- EPS
- 1.16
- P/E
- 62.64
- Div yield
- 0.44%
More statistics
- Low
- 72.66
- High
- 72.73
- Forward P/E
- 31.44
- Beta
- 1.29
- Short ratio
- 2.42
- Inst. own
- 112.55%
- Dividend
- 0.32
- Ex-div date
- Aug 23, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 72.44
- 200-d avg
- 63.13
- 1y target
- 70.50
6M chart
Events in this range
- May 6, 2026Earnings: 0.53; estimate 0.55; surprise -3.64%
- May 18, 2026Dividend: 0.08
- Jun 26, 2026Downgrade: Stephens & Co. · Overweight → Equal-Weight
- Jun 29, 2026Downgrade: Citigroup · Buy → Neutral
- Jun 30, 2026Downgrade: Benchmark · Buy → Hold
- Jun 30, 2026Downgrade: TD Cowen · Buy → Hold
- Jul 9, 2026Downgrade: RBC Capital · Outperform → Sector Perform
- Aug 12, 2026Earnings: 0.52; estimate 0.519; surprise 0.19%
- Aug 13, 2026Downgrade: Wells Fargo · Overweight → Equal-Weight
- Aug 17, 2026Dividend: 0.08
- Aug 24, 2026Dividend: 0.08
Signals (9)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
Financial health
Altman Z-Score
15.96 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E 60.4×
FY 2017 5y median 60.4× FY 2026
P/S 9.1×
FY 2017 5y median 9.7× FY 2026
P/B 5.2×
FY 2017 5y median 5.5× FY 2026
P/FCF 41.9×
FY 2017 5y median 47.8× FY 2026
EV/EBITDA 32.2×
FY 2017 5y median 33.2× FY 2026
EV/Sales 9.1×
FY 2017 5y median 10.0× FY 2026
FCF Yield 2.4%
FY 2017 5y median 2.1% FY 2026
Profitability
Gross Margin 65.8%
FY 2017 5y median 66.4% FY 2026
Operating Margin 20.7%
FY 2017 5y median 20.7% FY 2026
Net Margin 15.0%
FY 2017 5y median 15.0% FY 2026
ROE 8.6%
FY 2017 5y median 8.6% FY 2026
ROIC 7.5%
FY 2017 5y median 7.5% FY 2026
ROA 6.8%
FY 2017 5y median 6.8% FY 2026
Growth (YoY)
Revenue -0.4%
FY 2017 FY 2026
Operating Income 146.3%
FY 2017 FY 2026
EPS (diluted) 152.2%
FY 2017 FY 2026
Free Cash Flow 2.6%
FY 2017 FY 2026
Financial Health
Current Ratio 4.5×
FY 2017 5y median 3.9× FY 2026
Quick Ratio 3.4×
FY 2017 5y median 2.7× FY 2026
Debt / Equity 0.1×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA 0.1×
FY 2017 5y median 0.6× FY 2026
Interest Coverage 46.6×
FY 2017 5y median 26.2× FY 2026
Dividends
Dividend Yield 0.5%
FY 2017 5y median 0.4% FY 2026
Payout Ratio 27.4%
FY 2017 5y median 27.4% FY 2026
Annual · latest fiscal year ends 2026-06-30